Thermo Scientific at ISICEM 2013

In ICU
Thu, 14 Mar 2013

Thermo Scientific will be exhibiting at the 33^rd ISICEM in Brussels and will be presenting its procalcitonin (PCT) biomarker. Early identification of sepsis is crucial to improving patient outcomes. Yet sepsis can be difficult to differentiate from nonbacterial infections. Procalcitonin (PCT) is a biomarker that exhibits a rapid, clinically significant response to severe bacterial infection. In patients with sepsis, PCT levels increase in correlation to the severity of the infection. Adding the PCT biomarker assay can help improve the accuracy of risk assessment in sepsis and guide therapeutic decisions.

About Thermo Scientific

BRAHMS GmbH, Part of Thermo Fisher Scientific, specialises in innovative products that facilitate earlier diagnosis of diseases and better control of therapy, thus enabling doctors to provide more efficient and economic patient care. Major fields of activity are diagnosis of infectious and thyroid diseases, cardiology and pneumology as well as sepsis, tumors, and Down's syndrome.

To find out more please visit Thermo Scientific at ISICEM 2013, stand nr. 2.47 - 2.88 or visit: thermoscientific.com/procalcitonin

«« Today is the World Kidney Day!

Orion Pharma at ISICEM 2013 »»

ISICEM, Biomarkers, ISICEM2013, ThermoScientific, Sepsis

Latest Articles

Decision-Making in the ICU
- ICU Journal Article
- 19/04/2024
Decision-making in the ICU is a multifaceted process that involves clinical assessment, collaboration among multidisciplinary teams, ethical considerations, evidence-based practice, communication, and continuous adaptation to evolving clinical scenarios. Balancing the complex factors requires
READ MORE
Dealing With Uncertainty in ICU Decision-Making: A Practical Guide
- ICU Journal Article
- 19/04/2024
When the stakes are high, and the path ahead is uncertain, the decisions made, especially if a patient continues to worsen, can be sources of self-torment and can haunt us for a long time. Our goal is to suggest ways to steer decision-making for intensivists in the face of uncertainty by prop
READ MORE
The Least Bad Decision: Crisis Standards of Care After the Pandemic
- ICU Journal Article
- 19/04/2024
COVID-19 was an emergency that lasted for years and left few regions of the world untouched. The pandemic shone a spotlight on both the strengths and weaknesses of our disaster planning. What worked, what did not, and how can we better plan for future emergencies? The COVID-19 pandemic fo
READ MORE

ISICEM, Biomarkers, ISICEM2013, ThermoScientific, Sepsis Thermo Scientific will be exhibiting at the 33rd ISICEM in Brussels and will be presenting its procalcitonin (PCT) biomarker. Early identification of seps...